Navigation Links
MichBio Announces Annual Business Meeting Keynote and Pre-Meeting Workshop

ANN ARBOR, Mich., March 17 /PRNewswire-USNewswire/ -- MichBio, the association for Michigan biosciences, will host Harry Stylli, Ph.D., president and CEO of San Diego, CA-based Sequenom, Inc. as the keynote speaker for its May 6 Annual Business Meeting at the Kensington Court Hotel in Ann Arbor. Sequenom has established a presence in Michigan with recent acquisitions of the Center for Molecular Medicine (CMM) in Grand Rapids and Ann Arbor-based Sensigen.

Dr. Harry Stylli has a track record of nearly two decades, demonstrating entrepreneurial leadership in the biotechnology and pharmaceutical industries, and has broad experience in successfully translating innovative technology into commercial opportunities. He was appointed president, CEO, and a board member of Sequenom, Inc. in 2005. Most recently, he served as president and CEO of Xencor, Inc., a privately held biotechnology company. Previously, Dr. Stylli was president and CEO of CovX Pharmaceuticals. Dr. Stylli co-founded Aurora Biosciences in 1995, and in 2001 he was key to the success of Aurora's acquisition by Vertex Pharmaceuticals. Following the merger, Dr. Stylli continued on with the company as president of Aurora Biosciences and Panvera. From 1987 to 1995, Dr. Stylli held various positions with GlaxoSmithKline. Dr. Stylli is a director of Molecular Insight Pharmaceuticals, Inc., and an advisor to Nanosyn. He has a B.S. degree from the University of East London, U.K., a Ph.D. from London University's Faculty of Medicine, and an M.B.A. from the U.K.'s Open University.

The MichBio Annual Business Meeting draws the industry's leaders and most influential bioscience professionals from across the state. It will be held at the Kensington Court Hotel in Ann Arbor, MI. Reception and networking begin at 5:00 p.m., followed by a dinner meeting at 6:30 p.m. and keynote address at 7:15 p.m. The cost before May 1 is $80 for members, $110 for non-members. After May 1 the cost increases to $100 and $130, respectively. For sponsorship information and to register, please visit

Workshop Will Lead into Annual Meeting

Immediately preceding its Annual Meeting, MichBio will present a workshop titled, "Strengthening Your Bioscience Company: Business Strategies to Survive and Grow in a Difficult Economy." The workshop will provide emerging and established companies with the tools and knowledge to improve cash flow, protect and grow investment and prepare for the longer term. Participants will discuss:

  • How the stimulus package affects their businesses, and how to create tax savings.
  • R&D tax credits and how to streamline and fund R&D as well as the patent implications of these measures.
  • Strategic business planning and how to plan for the future, given the current economic climate.

The program will be led by senior company representatives from the Troy, MI-based certified public accounting and consulting firm, Doeren Mayhew and Grand Rapids-based Warner Norcross & Judd.

The workshop will run from 1:00-5:00 p.m. at the Kensington Court on May 6, prior to the Annual Meeting reception. The cost is $75 for MichBio members and $100 for non-members. The combined price for the workshop and Annual Meeting is $130 for members and $185 for non-members. Registration is at

MichBio is committed to driving the growth of Michigan's bioscience industry and to fostering the collective impact of its members by serving as their unified voice and by providing them with education, information, connections and other services. MichBio members include biosciences companies, academic and research institutions, bioscience service providers, and related organizations.

Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. MichBio Will Publish 2009 Michigan Biosciences Directory and Resource Guide
2. MichBio Expo Draws Nearly 500 Professionals; Career Day Raises Profile
3. MichBio Expo Will Feature Sessions for Michigan Manufacturers Interested in Entering Medical Device Market
4. Presenters Announced For MichBio Expos Emerging Business Showcase
5. Early-Bird Pricing Ends Soon for MichBio Expo Attendees and Exhibitors; Award Nominations Due Nov. 1
6. Start-Up and Emerging Biotech Companies Will Tell Their Stories at Biosciences Showcase Planned for MichBio Expo
7. Christine Poon Will Keynote MichBio Expo
8. MichBio Will Host Workshop on Capital Formation Prior to April 22 Annual Meeting
9. MichBio Announces Annual Meeting Keynote and Pre-Meeting Workshop
10. MichBio Responds to Governors Plan to Repeal Tort Reform Laws
11. MichBio Expo Opens in Lansing Next Week
Post Your Comments:
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
(Date:10/10/2017)... SANTA CRUZ, Calif. , Oct. 10, 2017 /PRNewswire/ ... SBIR grant from the NIH to develop RealSeq®-SC (Single ... preparation kit for profiling small RNAs (including microRNAs) from ... Cell Analysis Program highlights the need to accelerate development ... "New techniques for ...
(Date:10/9/2017)... , ... October 09, 2017 , ... The award-winning American ... broadcast first quarter 2018. American Farmer airs Tuesdays at 8:30aET on RFD-TV. , ... faced with the challenge of how to continue to feed a growing nation. At ...
(Date:10/7/2017)... Phoenix, Arizona (PRWEB) , ... ... ... than 15 years’ experience providing advanced instruments and applications consulting for microscopy ... the in-house expertise in application consulting, Nanoscience Analytical offers a broad range ...
Breaking Biology Technology:
(Date:4/5/2017)... YORK , April 5, 2017 Today ... is announcing that the server component of the HYPR ... known for providing the end-to-end security architecture that empowers ... HYPR has already secured over 15 million ... makers including manufacturers of connected home product suites and ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... Trends, opportunities and forecast in this market ... (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, vein ... use industry (government and law enforcement, commercial and retail, ... others), and by region ( North America ... Pacific , and the Rest of the World) ...
Breaking Biology News(10 mins):